華斯股份(002494.SZ):2019年度淨利潤升0.15%至1688.98萬元
格隆匯4月7日丨華斯股份(002494.SZ)披露2019年年度報告,實現營業收入4.77億元,同比下降4.83%;歸屬於上市公司股東的淨利潤1688.98萬元,同比增長0.15%;歸屬於上市公司股東的扣除非經常性損益的淨利潤943.89萬元,同比增長20608.20%;基本每股收益0.0445元。
2019年,公司在董事會的領導下,在管理層和全體職工的共同努力下,緊緊圍繞董事會確定的年度戰略經營目標,推動公司治理水平的提高、努力調整業務結構、加快技術創新,管理水平明顯提升,企業文化穩步推進,節能減排效果明顯,市場競爭力進一步增強,公司在行業中的龍頭地位繼續增強。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.